Article
Relationships between memory decline and the use of metformin or DPP4 inhibitors in people with type 2 diabetes with normal cognition or Alzheimer's disease, and the role APOE carrier status.
Alzheimer's & dementia : the journal of the Alzheimer's Association - 1 Dec 2020
Wu Che-Yuan, Ouk Michael, Wong Yuen Yan, Anita Natasha Z, Edwards Jodi D, Yang Pearl, Shah Baiju R, Herrmann Nathan, Lanctôt Krista L, Kapral Moira K, MacIntosh Bradley J, Rabin Jennifer S, Black Sandra E, Swardfager Walter
Abstract excerpt
INTRODUCTION: Few studies have examined memory decline among patients with type 2 diabetes using different oral hypoglycemic drugs. METHODS: Participants with normal cognition (NC) or Alzheimer's disease (AD) dementia using a hypoglycemic medication (2005 to 2019) were identified from the National Alzheimer's Coordinating Center database. Delayed memory was assessed using the Wechsler Memory Scale Revised-Logical...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.